Healthpeak Properties, IncNYSE: DOC
Real Estate · Health Care REITs
$16.45
+1.70%
Vol: 7.5M
Research Digest
Friday, May 1, 2026
Healthpeak closes South San Francisco campus acquisition; maintains 7.23% dividend yield
Healthpeak closed $600M acquisition of 1.4M SF campus in South San Francisco (60% occupied) in Jan 2026. Company also disposed $325M of outpatient medical assets in Q4 2025. 2025 revenue increased 4.52% to $2.82B; earnings decreased 70.91% due to lab headwinds. 2026 guidance reflects lab occupancy challenges. Analysts average Buy rating with $19.04 PT (+18.11% upside).
Previous Market Intelligence
13 daysApr 30Healthpeak Properties declares Q2 dividends; Q1 earnings scheduled for May 5Neutral▶
Healthpeak Properties (DOC) declared monthly Q2 2026 dividends of $0.10167/share (annualized $1.22) on April 6. Company announced Q1 2026 results release for May 5 after-hours with May 6 conference call. Recent analyst moves include Morgan Stanley cutting price target from $21.00 to $18.00, while Scotiabank raised to Hold. Stock down 3.56% week-over-week and 4.88% month-over-month, though analysts maintain Buy avg rating with $19.04 12-month target (18% upside). Monthly dividend yield strong at 7.63%.
Apr 16Healthpeak Properties announced $925 million transaction activity including South San Francisco campus acquisitionPositive▶
Healthpeak Properties (DOC) announced $925 million in transaction activity aligned with capital reallocation strategy. The company closed acquisition of a 1.4-million square foot Gateway Boulevard campus in South San Francisco for $600 million, expanding its biotech portfolio to 6.5 million square feet across 210 acres. Additionally, DOC closed outpatient medical dispositions totaling $325 million in Q4 2025, representing 834,000 square feet of stabilized assets at low-6% cap rates.
Apr 15Analyst upgrade and dividend affirmation as Healthpeak eyes senior housing REIT spinoff while facing shareholder pressure.Mixed▶
Wall Street Zen upgraded Healthpeak Properties to Hold on April 14, reversing a prior sell rating. The company declared monthly Q2 2026 dividends of $0.10167 per share and closed a $400 million unsecured term loan to strengthen liquidity. Healthpeak is proceeding with plans to launch a senior housing focused REIT. Q4 earnings beat estimates but the stock declined 7.1% post-announcement. The company's high 7.01% dividend yield attracts income investors.
Apr 14Healthpeak Properties upgraded from Sell to Hold by Wall Street Zen; Q1 2026 earnings scheduled for May 5-6.Neutral▶
Healthpeak Properties reported Q4 earnings beating estimates ($0.47 EPS vs. $0.45 consensus) but experienced 7.1% post-announcement stock decline. Wall Street Zen upgraded from Sell to Hold on April 14. Board affirmed monthly dividend at $0.10167 per share. Consensus rating is Hold with $19.19 average price target.
Apr 13Healthpeak Properties upgraded to Hold by Wall Street Zen on April 12 as dividend confirmed at $0.10167 per share.Neutral▶
Healthpeak Properties declared a monthly common stock cash dividend of $0.10167 per share on April 6 for Q2. Wall Street Zen upgraded the stock from Sell to Hold on April 12. Robert W. Baird decreased target from $20 to $19 with Outperform rating.
Apr 10Healthpeak Properties declares Q2 2026 monthly dividends of $0.10167 per share; Q1 earnings call scheduled for May 6.Neutral▶
Healthpeak Properties announced monthly dividends for Q2 2026 and scheduled Q1 earnings call for May 6. The company continues to navigate headwinds from declining life science occupancy and higher refinancing costs, though outpatient medical and senior housing segments show improvement.
Apr 9HealthPeak Properties announces $925M transaction activity and new Q1 earnings guidance amid Janus Living IPO momentum.Neutral▶
HealthPeak Properties Inc (DOC) disclosed $925 million in transaction activity highlighting continued capital recycling strategy, including $600M acquisition of South San Francisco life science campus completed in January 2026. The company advances its Janus Living senior housing IPO while managing headwinds from life science lab occupancy decline and refinancing costs. Q4 earnings beat estimates but stock declined 7.1% post-announcement, reflecting market concerns over near-term pressures. Stock is down 5.38% weekly and 11.20% over the past year, pressured by life science sector challenges. Dividend remains strong at ~7.01% yield supporting passive income investors. Q1 2026 earnings scheduled for May 6, 2026 with conference call at 10:00 a.m. ET.
Apr 8Healthpeak Properties declares monthly dividends for Q2 2026 and pursues capital allocation strategy.Mixed▶
Healthpeak announced Q2 2026 monthly dividends on April 6, reflecting its REIT commitment to shareholders. The company reported Q4 2025 earnings that beat estimates but experienced a 7.1% post-announcement stock decline. With ongoing headwinds from life science lab occupancy decline and refinancing costs affecting 2026 guidance, Healthpeak offsets near-term challenges through senior housing strength via Janus Living's IPO completion and active capital recycling. The $925M transaction activity, including a new $2.4B liquidity position, supports strategic flexibility.
Apr 7No significant overnight updatesNeutral▶
No material news in the last 48 hours.
Apr 6Janus Living IPO raised $966M; Healthpeak beat Q4; analyst PT cuts.Mixed▶
Janus Living (Healthpeak spinoff) IPO raised $966M at $20/share. Healthpeak beat Q4 with FFO $0.47 above forecasts. Baird cut PT to $19 (Outperform) and Citi issued 30-day upside catalyst watch on April 1.
Apr 3HealthPeak Properties price target cut by Citigroup to $17.50 as FFO guidance declines nearly 6% for 2026.Negative▶
Citigroup analysts reduced HealthPeak Properties' price target from $18.00 to $17.50 while maintaining neutral rating. FY 2026 guidance set at 1.700-1.740 EPS with FFO forecast down nearly 6% to $1.73 per share versus $1.84 in 2025. The company plans to spin off Janus Living, a pure-play senior housing REIT.
Apr 2Healthpeak Properties reports Q4 results and announces Janus Living REIT spinoff plan; completes $925 million in transactions.Mixed▶
Healthpeak completed $925 million in transactions including a $600 million acquisition of a 1.4 million square foot South San Francisco campus and $325 million in outpatient medical dispositions. The company plans to spin off Janus Living as a dedicated senior housing REIT to unlock shareholder value. Q1 2026 guidance projects FFO as adjusted of $0.44 per share, down 4.4% YoY. Stock declined 7.1% post-announcement despite beating estimates.
Apr 1Healthpeak Properties announced $925 million in transaction activity, including $600M South San Francisco acquisition.Positive▶
Healthpeak closed $600M acquisition of 1.4M sq ft campus in South San Francisco and divested outpatient medical properties for $325M. Announced planned IPO of Janus Living senior housing REIT. Closed $400M unsecured delayed-draw term loan.
Sector Peers
| Company | Price | Day | 1M | Fwd P/E | Beta | Mkt Cap |
|---|---|---|---|---|---|---|
| WELLWELLTOWER | $217.35 | +0.00% | +8.2% | 66.1x | — | $153.2B |
| VTRVENTAS | $88.07 | +0.24% | +5.9% | 96.9x | 0.77 | $42.7B |
| DOCHEALTHPEAK | $16.45 | +1.70% | -3.0% | 119.8x | 1.08 | $11.2B |
| PLDPROLOGIS | $141.40 | -0.43% | +7.3% | 41.8x | 1.41 | $132.4B |
| EQIXEQUINIX | $1,082.36 | -0.04% | +6.6% | 49.5x | 1.00 | $106.8B |
| AMTAMERICAN | $181.72 | -0.54% | +3.7% | 26.4x | 0.93 | $85.1B |
Key Fundamentals
RSI (14-Day)
52-Week Range
Moving Averages
Price below 200d MA — bearish structure.